• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过配方优化解决融合型单克隆抗体的液-液相分离。

Resolving Liquid-Liquid Phase Separation for a Peptide Fused Monoclonal Antibody by Formulation Optimization.

机构信息

Drug Product Technologies, Amgen, Thousand Oaks 91320.

Discovery Attribute Sciences, Amgen, Thousand Oaks 91320.

出版信息

J Pharm Sci. 2021 Feb;110(2):738-745. doi: 10.1016/j.xphs.2020.09.020. Epub 2020 Sep 19.

DOI:10.1016/j.xphs.2020.09.020
PMID:32961238
Abstract

Liquid-liquid phase separation (LLPS) of protein solutions has been usually related to strong protein-protein interactions (PPI) under certain conditions. For the first time, we observed the LLPS phenomenon for a novel protein modality, peptide-fused monoclonal antibody (pmAb). LLPS emerged within hours between pH 6.0 to 7.0 and disappeared when solution pH values decreased to pH 5.0 or lower. Negative values of interaction parameter (k) and close to zero values of zeta potential (ζ) were correlated to LLPS appearance. However, between pH 6.0 to 7.0, a strong electrostatic repulsion force was expected to potentially avoid LLPS based on the sequence predicted pI value, 8.35. Surprisingly, this is significantly away from experimentally determined pI, 6.25, which readily attributes the LLPS appearances of pmAb to the attenuated electrostatic repulsion force. Such discrepancy between experiment and prediction reminds the necessity of actual measurement for a complicated modality like pmAb. Furthermore, significant protein degradation took place upon thermal stress at pH 5.0 or lower. Therefore, the effects of pH and selected excipients on the thermal stability of pmAb were further assessed. A formulation consisting of arginine at pH 6.5 successfully prevented the appearance of LLPS and enhanced its thermal stability at 40 °C for pmAb. In conclusion, we have reported LLPS for a pmAb and successfully resolved the issue by optimizing formulation with aids from PPI characterization.

摘要

液-液相分离(LLPS)的蛋白质溶液通常与在某些条件下强烈的蛋白质-蛋白质相互作用(PPI)有关。我们首次观察到新型蛋白模式肽融合单克隆抗体(pmAb)的 LLPS 现象。LLPS 在 pH 值 6.0 到 7.0 之间的数小时内出现,并在溶液 pH 值降低到 pH 5.0 或更低时消失。相互作用参数(k)的负值和接近零的 Zeta 电位(ζ)值与 LLPS 的出现相关。然而,在 pH 值 6.0 到 7.0 之间,根据预测的序列等电点值 8.35,预计会存在强烈的静电斥力,从而可能避免 LLPS。令人惊讶的是,这与实验确定的等电点值 6.25相差甚远,这很容易将 pmAb 的 LLPS 归因于静电斥力的减弱。这种实验与预测之间的差异提醒我们,对于像 pmAb 这样复杂的模式,实际测量的必要性。此外,在 pH 值为 5.0 或更低的热应激下,会发生显著的蛋白质降解。因此,进一步评估了 pH 值和选定赋形剂对 pmAb 热稳定性的影响。在 pH 值为 6.5 时,包含精氨酸的配方成功地防止了 LLPS 的出现,并增强了 pmAb 在 40°C 时的热稳定性。总之,我们已经报道了 pmAb 的 LLPS,并通过利用 PPI 特性表征来优化配方成功解决了该问题。

相似文献

1
Resolving Liquid-Liquid Phase Separation for a Peptide Fused Monoclonal Antibody by Formulation Optimization.通过配方优化解决融合型单克隆抗体的液-液相分离。
J Pharm Sci. 2021 Feb;110(2):738-745. doi: 10.1016/j.xphs.2020.09.020. Epub 2020 Sep 19.
2
Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions.通过破坏分子间静电相互作用,对具有液-液相分离问题的单克隆抗体进行了过程优化和蛋白质工程改造,从而缓解了其生产挑战。
MAbs. 2019 May/Jun;11(4):789-802. doi: 10.1080/19420862.2019.1599634. Epub 2019 Apr 14.
3
Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.阐明不同类型添加剂作用下单抗溶液液-液相分离背后的弱蛋白-蛋白相互作用机制。
Eur J Pharm Biopharm. 2017 Nov;120:1-8. doi: 10.1016/j.ejpb.2017.07.012. Epub 2017 Jul 25.
4
Effect of Excipients on Liquid-Liquid Phase Separation and Aggregation in Dual Variable Domain Immunoglobulin Protein Solutions.辅料对双可变域免疫球蛋白蛋白溶液中液-液相分离和聚集的影响。
Mol Pharm. 2016 Mar 7;13(3):774-83. doi: 10.1021/acs.molpharmaceut.5b00668. Epub 2016 Jan 26.
5
Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure.基于晶体结构指导的治疗性抗体工程,以改善粘度和相分离
Mol Pharm. 2016 Mar 7;13(3):915-23. doi: 10.1021/acs.molpharmaceut.5b00817. Epub 2016 Feb 18.
6
Adenosine Triphosphate-Induced Rapid Liquid-Liquid Phase Separation of a Model IgG1 mAb.三磷酸腺苷诱导模型 IgG1 单抗快速液-液相分离。
Mol Pharm. 2021 Jan 4;18(1):267-274. doi: 10.1021/acs.molpharmaceut.0c00905. Epub 2020 Dec 12.
7
Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.通过带电荷和不带电荷的优先排斥赋形剂抑制静电介导的抗体液-液相分离。
Mol Pharm. 2021 Mar 1;18(3):1285-1292. doi: 10.1021/acs.molpharmaceut.0c01138. Epub 2021 Feb 8.
8
Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.蛋白质溶液中乳光及液-液相分离的药学视角
Mol Pharm. 2016 May 2;13(5):1431-44. doi: 10.1021/acs.molpharmaceut.5b00937. Epub 2016 Apr 5.
9
Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation.利用聚乙二醇诱导的液-液相分离对抗体溶液的胶体稳定性进行定量评估。
Mol Pharm. 2014 May 5;11(5):1391-402. doi: 10.1021/mp400521b. Epub 2014 Apr 15.
10
Investigating Liquid-Liquid Phase Separation of a Monoclonal Antibody Using Solution-State NMR Spectroscopy: Effect of Arg·Glu and Arg·HCl.使用溶液态核磁共振光谱研究单克隆抗体的液-液相分离:精氨酸·谷氨酸和精氨酸·盐酸盐的影响
Mol Pharm. 2017 Aug 7;14(8):2852-2860. doi: 10.1021/acs.molpharmaceut.7b00418. Epub 2017 Jun 28.

引用本文的文献

1
Stability of Protein Pharmaceuticals: Recent Advances.蛋白质类药物的稳定性:最新进展
Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27.
2
Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies.利用综合分析数据集开发预测黏度和小鼠清除率的计算模型,该数据集涵盖了 83 种支架一致的单克隆抗体。
MAbs. 2023 Jan-Dec;15(1):2256745. doi: 10.1080/19420862.2023.2256745.